BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6428843)

  • 1. Effect of glyburide on metabolic control and insulin binding in insulin-dependent diabetes mellitus.
    Goldman J; Tamayo RC; Whitehouse FW; Kahkonen DM
    Diabetes Care; 1984; 7 Suppl 1():106-12. PubMed ID: 6428843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide.
    Grunberger G
    J Lab Clin Med; 1993 Apr; 121(4):555-61. PubMed ID: 8454937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.
    Bieger WP; Dlugosch R; Rettenmeier A; Holler HD; Bert H; Schwarz W; Fiehn W; Merkt J; Weicker H
    Klin Wochenschr; 1984 Jul; 62(13):631-9. PubMed ID: 6434794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyclosporine on insulin binding to erythrocytes in type 1 diabetes mellitus of recent onset.
    Behme MT; Dupre J; Stiller CR
    Clin Invest Med; 1988 Apr; 11(2):113-22. PubMed ID: 3293865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea.
    Gutniak M; Karlander SG; Efendić S
    Diabetes Care; 1987; 10(5):545-54. PubMed ID: 2890501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.
    Nathan DM; Roussell A; Godine JE
    Ann Intern Med; 1988 Mar; 108(3):334-40. PubMed ID: 3124685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on B-cell function after segmental pancreatic allotransplantation in diabetic patients.
    Gunnarsson R; Collste H; Lundgren G; Ostman J; Groth CG
    Horm Metab Res Suppl; 1983; (13):42-6. PubMed ID: 6345317
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of glyburide in type II diabetes mellitus. Studies of monocyte membrane fluidity, lipid composition, and insulin binding.
    Neufeld ND; Harris M; Corbo LM; Koduri A
    Diabetes; 1987 Dec; 36(12):1351-5. PubMed ID: 3119405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.
    Riddle MC; Hart JS; Bouma DJ; Phillipson BE; Youker G
    Diabetes Care; 1989 Oct; 12(9):623-9. PubMed ID: 2507265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin release in children with diet-treated diabetes.
    Weber B
    Isr J Med Sci; 1972 Jun; 8(6):842-3. PubMed ID: 4626315
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects.
    Gavin JR
    Am J Med; 1985 Sep; 79(3B):34-42. PubMed ID: 3931460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of glyburide on insulin sensitivity in type I diabetic patients.
    Garrel DR; Picq R; Bajard L; Harfouche M; Tourniaire J
    J Clin Endocrinol Metab; 1987 Nov; 65(5):896-900. PubMed ID: 3117833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of type I diabetes with a combination of glyburide and insulin.
    Gums JG; Curry RW; Montes de Oca G; Skluth HA; Reynolds LR
    Ann Pharmacother; 1992 Jun; 26(6):757-62. PubMed ID: 1611155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the time factor in the pancreatic and extrapancreatic mechanisms of action of glibenclamide].
    Tikhonova EP; Poltorak VV; Levchenko TP; Gladkikh AI; Ladogubets EV
    Probl Endokrinol (Mosk); 1987; 33(2):29-33. PubMed ID: 3110762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin receptors of adipose tissue in patients newly diagnosed with insulin-dependent diabetes mellitus].
    Evdokimova NIu; Efimov AS; Bezdrobnyĭ IuV
    Vopr Med Khim; 1985; 31(2):64-8. PubMed ID: 3890366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin receptors in diabetes mellitus].
    Tankova Ts
    Vutr Boles; 1989; 28(6):8-12. PubMed ID: 2699128
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of glyburide on beta cell responsiveness to glucose in non-insulin-dependent diabetes mellitus.
    O'Meara NM; Shapiro ET; Van Cauter E; Polonsky KS
    Am J Med; 1990 Aug; 89(2A):11S-16S; discussion 51S-53S. PubMed ID: 2117385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea.
    Riddle M; Hart J; Bingham P; Garrison C; McDaniel P
    Am J Med Sci; 1992 Mar; 303(3):151-6. PubMed ID: 1595776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.